What we found on the web about Peginterferon
Peginterferon alfa-2a - Wikipedia, the free encyclopedia
Pegylated interferon alfa-2a (40 kDa; commercial name Pegasys) is an antiviral drug discovered at the pharmaceutical company F. Hoffmann-La Roche; it has a dual mode of action ...
PegaSys - Wikipedia, the free encyclopedia
MS-DOS based BBS software based on Telegard, used in the early 1990s. Used on The Echo Chamber, Inacomp, The Dark Alley, The Sensual BBS, The Wormhole and The Atomic Cafe.
PBM Drug Monograph Template
Peginterferon alfa-2a ... Peginterferon alpha-2a has been approved for the treatment of ... side effect profile of peginterferon alpha-2a (40D) is similar ...
Peginterferon - Peginterferon Drug and Treatment for Chronic Hepatitis
Peginterferon is a powerful antiviral drug treatment for chronic hepatitis B and C. Here is information on side effects, costs, effectiveness and warnings.
FDA-Approved Combination Therapy
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and vaccines ... to Peginterferon alfa and ...
Hepatitis C - peginterferon alfa and ribavirin
The summary of the published technology appraisal on Hepatitis C - peginterferon alfa and ribavirin. It links to the published guidance and key documents.
Peg Interferon, PEG-INTRON, Interferon Alfa-2b - Chemotherapy Drugs ...
PEG Interferon alfa-2b is a biologic response modifier. ... is the trade name for peg interferon. Interferon alfa-2b and PEG conjugate are other names for peg interferon. ...
Pegasys (Peginterferon alfa-2a) Drug Information: Uses, Side Effects ...
Learn about the prescription medication Pegasys (Peginterferon alfa-2a), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
Peginterferon Alfa-2a consumer information from Drugs.com
Peginterferon Alfa-2a patient ... Information for the Consumer > Peginterferon Alfa-2a ... Peginterferon alfa-2a (peg in-ter-FEER-on alf-a 2a) is a ...
Peginterferon - Hutchinson encyclopedia article about Peginterferon
interferon. Naturally occurring cellular protein that makes up part of mammalian defences against viral disease. Three types (alpha, beta, and gamma) are produced by infected cells ...
Peginterferon Alfa 2b - Drugs & Treatments - Revolution Health
What is the most important information I should know about Peginterferon Alfa 2b? ... Where can I get more information regarding Peginterferon Alfa 2b? ...
PEGINTERFERON ALFA 2B - INJECTABLE (PEG-Intron) side effects, medical ...
Consumer information about the medication PEGINTERFERON ALFA 2B - INJECTABLE (PEG-Intron), includes side effects, drug interactions, recommended dosages, and storage information.
MedlinePlus Drug Information: Peginterferon alfa-2b
Peginterferon alfa-2b may cause or worsen the following conditions that may be ... You may take peginterferon alpha-2b with another medication called ribavirin ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Peginterferon

1RH2%20Recombinant%20Human%20Interferon-Alpha%202b-01.png

IFNs belong to the large class of glycoproteins known as cytokines. Although they are named after their ability to "interfere" with viral replication within host cells, IFNs have other functions: they activate immune cells, such as natural killer cells and macrophages; they increase recognition of infection or tumor cells by up-regulating antigen presentation to T lymphocytes; and they increase the ability of uninfected host cells to resist new infection by virus. Certain host symptoms, such as aching muscles and fever, are related to the production of IFNs during infection.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Peginterferon
Roche Women Honored as 2009 TWIN Awardees
PR Newswire via Yahoo! Finance
Three Roche employees were recognized for their significant contributions to industry in New Jersey at the 2009 TWIN Awards Dinner held April 30, 2009. Honored were Nancy Shore DiLella, J.D., senior counsel and managing attorney; Theresa Ma...
New drug offers hope against hepatitis C
Las Vegas Review-Journal
LOS ANGELES -- An experimental drug greatly increased the number of people who appeared to be cured of hepatitis C infection, according to results of midstage testing.
New England Journal Of Medicine Publishes Landmark Clinical Studies Of The Investigational Hepatitis C Virus Protease ...
Medical News Today
Two clinical studies published in this week's New England Journal of Medicine demonstrate that treatment with the investigational oral hepatitis C virus (HCV) protease inhibitor telaprevir dosed in combination with pegylated-interferon (peg...
Studies: Drug Shows Promise Against Hepatitis C
CBS 3 Philadelphia
An experimental drug greatly increased the number of people who appear to be cured of hepatitis C infection, according to results of mid-stage testing. The findings also suggest the drug telaprevir, made by Vertex Pharmaceuticals Inc., whic...
New Treatment Combo Better Against Hepatitis C
HealthDay via Yahoo! News
WEDNESDAY, April 29 (HealthDay News) -- Adding the antiviral drug telaprevir to standard treatment for hepatitis C increases the cure rate, two new studies show.
Improved Response To Hepatitis C Treatment, Duration Halved By Added Anti-Viral
Medical News Today
The addition of the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease, according to the results of study coordinated ...
Added anti-viral boosts response, shortens hepatitis C treatment duration
New Kerala
London, April 30 : A new study, conducted by researchers at the Duke Clinical Research Institute (DCRI), has found that adding the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and in...